Skip to main content

Table 5 Evaluation of events (cough) between the two groups is expressed as Relative Risk and Relative Risk reduction (RR, RRR), 95% confidence intervals (CI) and p-values. A p-value smaller than 0.05 was considered statistically significant

From: Efficacy and safety of the syrup “KalobaTUSS®” as a treatment for cough in children: a randomized, double blind, placebo-controlled clinical trial

 

KalobaTUSS® (children with cough)

Placebo (children with cough)

RR (95% CI)

RRR (95% CI)

p

Night time cough after 4 days of treatment

34/54

43/52

0.76 (0.6–0.9)

0.24 (0.032–0.40)

0.0256

Night time cough after 8 days of treatment

7/54

22/52

0.306 (0.143–0.65)

0.69 (0.34–0.85)

0.0023

Day time cough after 4 days of treatment

38/54

45/52

0.81 (0.66–0.99)

0.18 (0.0032–0.33)

0.046

Day time cough after 8 days of treatment

8/54

24/52

0.32 (0.16–0.65)

0.68 (0.35–0.84)

0.0016